MarketCap
Facebook
X
TelegramAnnual report 2023
added 12-27-2025
Centogene N.V. Cash Conversion Cycle 2011-2026 | CNTG
Annual Cash Conversion Cycle Centogene N.V.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 50.2 | - | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 50.2 | 50.2 | 50.2 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Burning Rock Biotech Limited
BNR
|
149 | $ 17.56 | -5.39 % | $ 186 M |  China |
 |
Co-Diagnostics
CODX
|
-2.46 K | $ 1.46 | -10.44 % | $ 1.94 M |  USA |
 |
Agilent Technologies
A
|
111 | $ 112.25 | -0.88 % | $ 34.1 B | USA |
 |
Castle Biosciences
CSTL
|
31.6 | $ 18.84 | -0.21 % | $ 546 M | USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 16.07 | -0.74 % | $ 486 M | USA |
 |
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
142 | $ 140.65 | -1.81 % | $ 22.4 B | USA |
 |
Interpace Biosciences
IDXG
|
62.9 | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 20.22 | -1.32 % | $ 1.08 B | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 94.75 | -1.99 % | $ 6.39 B | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 418.79 | -0.09 % | $ 12.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | China |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 047.48 | 0.53 % | $ 21.6 B |  Schweiz |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Myriad Genetics
MYGN
|
49.3 | $ 3.63 | 0.14 % | $ 336 M | USA |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
82.4 | $ 8.26 | -1.2 % | $ 1.06 B | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 18.68 | -1.32 % | $ 418 M | USA |
 |
Natera
NTRA
|
81.5 | $ 188.85 | -4.1 % | $ 18.6 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 159.21 | 0.06 % | $ 7.89 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 25.26 | -0.94 % | $ 24 B |  Niderland |
 |
Guardant Health
GH
|
79.6 | $ 96.67 | -2.02 % | $ 12.1 B | USA |
 |
Personalis
PSNL
|
-1.89 | $ 6.5 | -3.13 % | $ 580 M | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
62 | $ 118.02 | 0.79 % | $ 9.73 B |  Irlanda |
 |
Senseonics Holdings
SENS
|
36.1 | $ 5.86 | 0.6 % | $ 245 M | USA |
 |
Soleno Therapeutics
SLNO
|
-398 | $ 52.98 | -0.02 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
172 | $ 2.31 | -4.04 % | $ 5.31 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 251.49 | -1.03 % | $ 20.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 441.01 | -1.61 % | $ 166 B | USA |
 |
Trinity Biotech plc
TRIB
|
136 | $ 0.6 | 3.48 % | $ 216 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Twist Bioscience Corporation
TWST
|
83.6 | $ 49.96 | -5.65 % | $ 2.99 B | USA |
 |
Neogen Corporation
NEOG
|
150 | $ 8.35 | -1.01 % | $ 1.81 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 187.79 | -0.08 % | $ 20.8 B | USA |